Here are five important stories that were overlooked in the media frenzy.
The Food and Drug Administration has asked Endo Pharmaceuticals to withdraw its Opana ER painkiller over concerns that the drug is too easily abused, the first time the agency has made such a move.
A new type of “waiver” from federal rules has dramatically expanded options for Medicaid beneficiaries, and could help other states serve those in need.
Congress has paved the way to letting nurse practitioners and physician assistants prescribe anti-addiction medication. But laws in many states stand in the way.
The FDA issued its strongest level of drug warnings Thursday concerning opioid pain-reliever use in children.
Sen. Claire McCaskill said prescription opioid sales have quadrupled since 1999, taking a financial toll on the government and a deadly toll on consumers.
Early medical procedures can dampen a child’s ability to perceive touch in the long run.
With an historic rise in fatal drug overdoses nationwide and a new president in the White House, the future is uncertain for programs trying to combat a growing public health crisis: opioid addiction.
A southern West Virginia town in the state’s poorest county has joined other communities in seeking to recoup the costs of dealing with opioid abuse.
With heroin deaths now surpassing gun homicides, hospitals have been retraining staff to minimize prescriptions of narcotic painkillers.
Additional Support Provided By:
